Anika Therapeutics
ANIK
ANIK
102 hedge funds and large institutions have $134M invested in Anika Therapeutics in 2025 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 38 increasing their positions, 33 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
30% less capital invested
Capital invested by funds: $191M → $134M (-$56.5M)
50% less call options, than puts
Call options by funds: $2K | Put options by funds: $4K
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
102
Holding in Top 10
1
Calls
$2K
Puts
$4K
Top Buyers
| 1 | +$2.05M | |
| 2 | +$838K | |
| 3 | +$815K | |
| 4 |
Millennium Management
New York
|
+$594K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$410K |
Top Sellers
| 1 | -$2.61M | |
| 2 | -$591K | |
| 3 | -$462K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$425K |
| 5 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$413K |
